(688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688317 · · 3 pages · Chinese
Summary by 6ix AI
Participants will include the chairman, general manager, and independent directors, among others. Investors can join the briefing online and submit questions in advance through the designated platform.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai ZJ Bio-Tech Co. Ltd on 6ix
Story so far
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Conducting Foreign Exchange Derivatives Trading Business
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Reversal of Asset Impairment for the First Three Quarters of 2026
Earlier from Shanghai ZJ Bio-Tech
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Report for Q3 2026
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Reversal of Asset Impairment for the First Three Quarters of 2026
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Conducting Foreign Exchange Derivatives Trading Business
- (688317)"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Third Repurchase of Shares through Call Auction in 2025 Reaching 3% of Total Share Capital and Results of Share Repurchase
Follow Shanghai ZJ Bio-Tech into a list and get an email when it puts out news.
Follow Shanghai ZJ Bio-Tech